Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. AIM ImmunoTech Inc. (AIM) is a stock that can certainly grab the attention of many ...
OCALA, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) -- (NYSE American: AIM) – (“AIM” or the “Company”), an immuno-pharma company focused on the research and ...
OCALA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) (“AIM” or the “Company”) today announced a reverse stock split (“Reverse Stock Split”) of its ...
OCALA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of ...
AIM ImmunoTech Inc. (AIM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
$AIM ($AIM) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $101,000 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results